Status:
COMPLETED
Liver Cancer Community Education
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
Pennsylvania Department of Health
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with highe...
Eligibility Criteria
Inclusion
- Speaks/reads English
- Lives in Philadelphia or receives healthcare at a community partner site in Philadelphia
Exclusion
- None
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2023
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04272619
Start Date
February 11 2020
End Date
April 6 2023
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111